Literature DB >> 24875738

A centrosomal route for cancer genome instability.

Guillermo de Cárcer1, Marcos Malumbres1.   

Abstract

Despite the widespread occurrence of aneuploidy in cancer cells, the molecular causes for chromosomal instability are not well established. Cyclin B2 is now shown to control a pathway - involving the centrosomal kinases aurora A and Plk1 and the tumour suppressor p53 - the alteration of which causes defective centrosome separation, aneuploidy and tumour development.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24875738     DOI: 10.1038/ncb2978

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  15 in total

Review 1.  A census of mitotic cancer genes: new insights into tumor cell biology and cancer therapy.

Authors:  Ignacio Pérez de Castro; Guillermo de Cárcer; Marcos Malumbres
Journal:  Carcinogenesis       Date:  2007-01-27       Impact factor: 4.944

2.  Oncogene-induced mitotic stress: p53 and pRb get mad too.

Authors:  Marcos Malumbres
Journal:  Cancer Cell       Date:  2011-06-14       Impact factor: 31.743

3.  Plk1 controls the Nek2A-PP1γ antagonism in centrosome disjunction.

Authors:  Balca R Mardin; Fikret G Agircan; Cornelia Lange; Elmar Schiebel
Journal:  Curr Biol       Date:  2011-06-30       Impact factor: 10.834

4.  Mad2 overexpression promotes aneuploidy and tumorigenesis in mice.

Authors:  Rocío Sotillo; Eva Hernando; Elena Díaz-Rodríguez; Julie Teruya-Feldstein; Carlos Cordón-Cardo; Scott W Lowe; Robert Benezra
Journal:  Cancer Cell       Date:  2006-12-28       Impact factor: 31.743

5.  A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers.

Authors:  Scott L Carter; Aron C Eklund; Isaac S Kohane; Lyndsay N Harris; Zoltan Szallasi
Journal:  Nat Genet       Date:  2006-08-20       Impact factor: 38.330

6.  Mutual inhibition of separase and Cdk1 by two-step complex formation.

Authors:  Ingo H Gorr; Dominik Boos; Olaf Stemmann
Journal:  Mol Cell       Date:  2005-07-01       Impact factor: 17.970

Review 7.  Mitotic chromosomal instability and cancer: mouse modelling of the human disease.

Authors:  Juan-Manuel Schvartzman; Rocio Sotillo; Robert Benezra
Journal:  Nat Rev Cancer       Date:  2010-02       Impact factor: 60.716

8.  Overexpression of Separase induces aneuploidy and mammary tumorigenesis.

Authors:  Nenggang Zhang; Gouquing Ge; Rene Meyer; Sumita Sethi; Dipanjan Basu; Subhashree Pradhan; Yi-Jue Zhao; Xiao-Nan Li; Wei-Wen Cai; Adel K El-Naggar; Veerabhadran Baladandayuthapani; Frances S Kittrell; Pulivarthi H Rao; Daniel Medina; Debananda Pati
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-26       Impact factor: 11.205

Review 9.  The spindle-assembly checkpoint in space and time.

Authors:  Andrea Musacchio; Edward D Salmon
Journal:  Nat Rev Mol Cell Biol       Date:  2007-04-11       Impact factor: 94.444

10.  Separase loss of function cooperates with the loss of p53 in the initiation and progression of T- and B-cell lymphoma, leukemia and aneuploidy in mice.

Authors:  Malini Mukherjee; Gouqing Ge; Nenggang Zhang; Eryong Huang; Lanelle V Nakamura; Marissa Minor; Viacheslav Fofanov; Pullivarthi H Rao; Alan Herron; Debananda Pati
Journal:  PLoS One       Date:  2011-07-25       Impact factor: 3.240

View more
  19 in total

1.  Therapeutic potential of mitotic interaction between the nucleoporin Tpr and aurora kinase A.

Authors:  Akiko Kobayashi; Chieko Hashizume; Takayuki Dowaki; Richard W Wong
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 2.  Issues in interpreting the in vivo activity of Aurora-A.

Authors:  Elena Shagisultanova; Roland L Dunbrack; Erica A Golemis
Journal:  Expert Opin Ther Targets       Date:  2014-11-11       Impact factor: 6.902

Review 3.  p53 in survival, death and metabolic health: a lifeguard with a licence to kill.

Authors:  Flore Kruiswijk; Christiaan F Labuschagne; Karen H Vousden
Journal:  Nat Rev Mol Cell Biol       Date:  2015-07       Impact factor: 94.444

Review 4.  Hallmarks of Cancer Applied to Oral and Oropharyngeal Carcinogenesis: A Scoping Review of the Evidence Gaps Found in Published Systematic Reviews.

Authors:  Miguel Ángel González-Moles; Saman Warnakulasuriya; María López-Ansio; Pablo Ramos-García
Journal:  Cancers (Basel)       Date:  2022-08-08       Impact factor: 6.575

5.  Human NINEIN polymorphism at codon 1111 is associated with the risk of colorectal cancer.

Authors:  Yukiko Yasuda; Akiko Sakai; Sachio Ito; Kaori Sasai; Akisada Ishizaki; Yoshiya Okano; Seito Kawahara; Yoshimi Jitsumori; Hiromasa Yamamoto; Nagahide Matsubara; Kenji Shimizu; Hiroshi Katayama
Journal:  Biomed Rep       Date:  2020-08-27

Review 6.  Fanconi anaemia and cancer: an intricate relationship.

Authors:  Grzegorz Nalepa; D Wade Clapp
Journal:  Nat Rev Cancer       Date:  2018-01-29       Impact factor: 60.716

Review 7.  Revisiting tumour aneuploidy - the place of ploidy assessment in the molecular era.

Authors:  Håvard E Danielsen; Manohar Pradhan; Marco Novelli
Journal:  Nat Rev Clin Oncol       Date:  2015-11-24       Impact factor: 66.675

8.  Increased Genetic Instability and Accelerated Progression of Colitis-Associated Colorectal Cancer through Intestinal Epithelium-specific Deletion of Klf4.

Authors:  Vincent W Yang; Yang Liu; Julie Kim; Kenneth R Shroyer; Agnieszka B Bialkowska
Journal:  Mol Cancer Res       Date:  2018-08-14       Impact factor: 5.852

Review 9.  Role of NEK2A in human cancer and its therapeutic potentials.

Authors:  Jiliang Xia; Reinaldo Franqui Machin; Zhimin Gu; Fenghuang Zhan
Journal:  Biomed Res Int       Date:  2015-02-01       Impact factor: 3.411

10.  PCR-Based Simple Subgrouping Is Validated for Classification of Gliomas and Defines Negative Prognostic Copy Number Aberrations in IDH Mutant Gliomas.

Authors:  Shunsuke Nakae; Hikaru Sasaki; Saeko Hayashi; Natsuki Hattori; Masanobu Kumon; Yuya Nishiyama; Kazuhide Adachi; Shinya Nagahisa; Takuro Hayashi; Joji Inamasu; Masato Abe; Mitsuhiro Hasegawa; Yuichi Hirose
Journal:  PLoS One       Date:  2015-11-11       Impact factor: 3.752

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.